Rita Assi

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Topics

Optical Coherence Tomography

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Rita Assi, Huda Salman
Harnessing the Potential of Chimeric Antigen Receptor T-Cell Therapy for the Treatment of T-Cell Malignancies: A Dare or Double Dare? Cells 11 (24) (2022)
Rita Assi, Huda Salman
Harnessing the Potential of Chimeric Antigen Receptor T-Cell Therapy for the Treatment of T-Cell Malignancies: A Dare or Double Dare? Cells 11 (24) (2022)
Rita Assi, Huda Salman
Harnessing the Potential of Chimeric Antigen Receptor T-Cell Therapy for the Treatment of T-Cell Malignancies: A Dare or Double Dare? Cells 11 (24) (2022)
Rita Assi, Huda Salman
Harnessing the Potential of Chimeric Antigen Receptor T-Cell Therapy for the Treatment of T-Cell Malignancies: A Dare or Double Dare? Cells 11 (24) (2022)
Christopher B Benton, Prajwal C Boddu, Courtney D D DiNardo, Prithviraj Bose, Feng Wang, Rita Assi, Naveen Pemmaraju, Devendra Kc, Sherry Pierce, Keyur Patel, Marina Konopleva, Farhad Ravandi, Guillermo Garcia Manero, Tapan Mahendra Kadia, Jorge Cortes, Hagop M Kantarjian, Michael Andreeff, Srdan Verstovsek
Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia. Cancer 125 (11) (2019)
Rita Assi, Hagop M Kantarjian, Tapan Mahendra Kadia, Naveen Pemmaraju, Elias J Jabbour, Nitin Jain, Naval G Daver, Zeev Estrov, Taisuke Uehara, Takashi Owa, Jorge E Cortes, Gautam Borthakur
Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome. Cancer 124 (13) (2018)